HEADER Seasonal Testing HOW COULD RAPID MOLECUL AR ASSAY RESULTS MAKE A DIFFERENCE? Clinicians often have to make immediate clinical decisions based only on symptoms.1-3 With that in mind, the ID NOW TM molecular platform was designed as a true point-of-care device to improve decision-making processes in any setting. More labs and healthcare professionals are making ID NOW their rapid molecular platform of choice.4 ID NOW™ INFLUENZA A & B 2 Results in 13 minutes or less, with early detection of positives in as little as 5 minutes5 ID NOW™ STREP A 2 Results in 6 minutes or less, with early detection of positives in as little as 2 minutes5 ID NOW™ RSV Results in 13 minutes or less 1. Stein J, et al. Performance characteristics of clinical diagnosis, a clinical decision rule, and a rapid influenza test in the detection of influenza infection in a community sample of adults. Annals of Emergency Medicine. 2005;46(5):412-9. 2. Mills J, et al. Rapid testing for respiratory syncytial virus in a paediatric emergency department: Benefits for infection control and bed management. The Journal of Hospital Infection. 2011;77(3):248-51. 3. Cohen JF, et al. Rapid antigen detection test for group A streptococcus in children with pharyngitis. Cochrane Database of Systematic Review. 2013:5-7. doi:10.1002/14651858.cd010502. 4. Alere™ i Instrument is now ID NOW™ Instrument by Abbott. SelectScience Web site. http://www.selectscience.net/products/alere--i-instrument?prodID=203785. Published 2019. 5. Clinical Trial Data. Held on File. © 2019 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. Any photos displayed are for illustrative purposes only. 120005619-01 08/19 20MS5681 henryschein.com/medical 5http://www.selectscience.net/products/alere--i-instrument?prodID=203785 http://www.henryschein.com/medical